The corpus luteum (CL) is essential for establishing pregnancy. If pregnancy does not occur during the estrous cycle, luteolysis is induced by prostaglandin (PG) F2alpha secreted from the uterus. Galectin-1, a beta-galactose-binding protein, is expressed in the functional CL of cows and increases the viability of bovine luteal steroidogenic cells (LSCs) by modifying the functions of membrane glycoproteins. The binding of galectin-1 to glycoproteins is blocked by alpha2,6-sialylation of the terminal galactose residues of glycoconjugates, which is catalyzed by a sialyltransferase (ST6Gal-I). However, the physiological role of alpha2,6-sialic acid in bovine CL is unclear. The level of alpha2,6-sialylation of the bovine CL was higher during the regressed-luteal stage than in other luteal stages. Lectin histochemistry revealed that alpha2,6-sialylated glycoconjugates were localized to luteal endothelial cells throughout the estrous cycle. In addition, alpha2,6-sialylated glycoconjugates concentrated to the membrane of LSCs during the regressed-luteal stage. PGF2alpha treatment for 72 h enhanced the expression of ST6Gal-I mRNA and the level of alpha2,6-sialylated glycoproteins in mid-LSCs. The level of alpha2,6-sialylated glycoproteins of late-stage LSCs (Days 15-17 after ovulation) was higher than that of mid-stage LSCs (Days 8-12 after ovulation), and galectin-1 increased the viability of midLSCs but not that of late-stage LSCs. Furthermore, galectin-1 increased the viability of late-LSCs when alpha2,6-sialic acid residues were removed by neuraminidase. The overall findings suggest that alpha2,6-sialylation stimulated by PGF2alpha contributes to luteolysis by inhibiting the luteotropic effects of galectin-1 in bovine CL.
INTRODUCTION
Luteolysis is characterized by a reduction in progesterone production (functional luteolysis) followed by a rapid decrease in the size of the corpus luteum (CL) (structural luteolysis) [1] . The major cause of structural luteolysis is luteal cell death (apoptosis) [2] [3] [4] [5] . During structural luteolysis, many cytokines from macrophages and neutrophils [6] and nitric oxide from luteal endothelial cells, in response to prostaglandin F2a (PGF2a), directly induce apoptosis of cells in the CL [1, [6] [7] [8] [9] . However, factors besides these key molecules may also be involved in luteolysis.
Glycosylation modulates a variety of physicochemical and biological properties of proteins such as protein folding, stability, targeting, and ligand binding [10] [11] [12] [13] [14] [15] . Most membrane proteins, including cell surface receptors, are glycosylated, and glycosylation status is important for their function [16, 17] . However, the role of glycosylation in the CL is not clear. Galectins are carbohydrate-binding proteins distributed intra-and extracellularly [18] . Their carbohydrate-binding specificity for b-galactoside is conserved by evolutionarily preserved carbohydrate recognition domains [18] . Extracellular galectins interact with cell surfaces oligosaccharide and form lattices that enhance the resident time of glycoproteins at the cell surface [19] . Among 15 members of galectins, galectin-1 is one of the most broadly distributed galectins in mammalian tissues, in which it modulates cell proliferation and survival [20] [21] [22] . Galectin-1 binds to N-acetyllactosamine (LacNAc) residues, which consist of galactose b-linked to N-acetylglucosamine, whereas its binding is completely inhibited by a2,6-sialylation of galactose [23] [24] [25] . ST6Gal-I is a sialyltransferase that catalyzes the binding of a2,6-sialic acid to galactose on glycan branch ends through an a2,6 linkage [26, 27] . The addition of a2,6-sialic acid to the terminal galactose of glycans masks the galectin recognition sites and inhibits the role of galectin-1 in adhesion, migration, and apoptosis [28] . We recently demonstrated that galectin-1 binds to the glycans on the surface of bovine luteal steroidogenic cells (LSCs) in the bovine mid-stage (mid-CL) and increases the viability of LSCs, suggesting that galectin-1 has a luteotropic function in the bovine CL [29] . The protein expression of galectin-1 in the cell membrane fraction is high in the CL during mid-luteal stages, whereas it decreases in the regressed CL [29] . The loss of luteotropic galectin-1 from the cell membrane may be due to a decreased ligand-binding ability and accompanied by modifications of ligand glycoconjugates such as a2,6-sialylation during luteolysis.
We hypothesized that the level of a2,6-sialylation is increased by luteolytic factors and that this increase inhibits the binding of galectin-1 to glycan, thereby weakening the survival signal of galectin-1 during luteolysis. To test this hypothesis, we examined 1) cyclic changes in the expression of ST6Gal-I mRNA and the level of a2,6-sialylation of glycoproteins in the bovine CL; 2) effects of luteolytic factors on the expression of ST6Gal-I mRNA and the level of a2,6-sialylation in cultured mid-LSCs; and 3) effect of a2,6-sialylation on galactin-1-enhanced viability of cultured midLSCs (Days 8-12 after ovulation) and late-LSCs (Days 15-17 after ovulation).
MATERIALS AND METHODS

Collection of Bovine CLs
Ovaries of Holstein cows were collected from a local slaughter house within 10-20 min after exsanguination. The stage of the estrous cycle was defined as described previously [30] . Ovaries with CLs were classified as early (Days 2-3 after ovulation), developing (Days 5-6), mid (Days 8-12), late (Days 15-17), and regressed (Days 19-21) luteal stages. After we determined CL stage, CL tissues were immediately separated from the ovaries, frozen rapidly in liquid nitrogen, and stored at À808C until processed for mRNA and protein analyses. For cell culture, ovaries with CLs were submerged in ice-cold physiological saline and transported to the laboratory.
Luteal Cell Isolation
Luteal tissue from mid-and late-luteal-stage CLs was enzymatically dissociated, and luteal cells were cultured as described previously [31] . Dissociated luteal cells from CLs were pooled. The luteal cells were suspended in a culture medium, Dulbecco modified Eagle medium and Ham F-12 medium (D/F) (1:1 [vol/vol]; product D8900; Sigma-Aldrich) containing 5% bovine serum (product 16170-078; Thermo Fisher Scientific) and 20 lg/ml gentamicin (product 15750-060; Thermo Fisher Scientific) under 5% CO 2 in air. Cell viability was greater than 85% as assessed by trypan blue exclusion assay. Cells consisted of approximately 70% small LSCs, 20% large LSCs, 10% endothelial cells or fibrocytes, and no erythrocytes. In this study, these cells were defined as LSCs. cells/well; product 3860-096; Iwaki) for cell viability test. The medium was replaced with D/F medium without phenol red (product D2906; Sigma-Aldrich) containing 0.1% bovine serum albumin (BSA) (product 23209; Thermo Fisher Scientific), 5 ng/ml sodium selenite (product S5261; Sigma-Aldrich), and 5 lg/ ml holo-transferrin (product T3400; Sigma-Aldrich), and the following experiments were carried out.
Cell Culture
Protein Fractionation and Extraction
CL tissues for Western blotting were homogenized on ice in a homogenization buffer (300 mM sucrose, 32.5 mM Tris-HCl, 2 mM EDTA, pH 7.4) using a tissue homogenizer (Physcotron model NS-50; Niti-On Inc.), followed by filtration through a metal wire mesh (grid size, 150 lm). For protein analysis, nuclei were removed from the tissue homogenates by centrifugation at 700 3 g for 5 min. The resultant supernatant was fractionated into membrane and cytoplasmic fractions by centrifugation at 20 000 3 g for 60 min. For protein analysis using LSCs, total cell lysate were used. After culture, LSCs were collected and lysed in lysis buffer consisting of 20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1.0% Triton X-100, 10% glycerol, and protease inhibitor cocktail (product 1697498; Roche). Their protein concentrations were determined by bicinchoninic acid (BCA) assay [32] . The proteins were then solubilized in SDS gel-loading buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, 1% b-mercaptoethanol, pH 6.8) and heated to 958C for 10 min.
Validation of the subcellular fractionation was performed by Western blotting using the antibodies against tumor necrosis factor receptor 1 (TNFR1) (product ab19139; Abcam) as a plasma membrane marker and b-actin (product A2228; Sigma-Aldrich) as a cytoplasm marker (data not shown).
Experiment 1: Cyclic Changes in Expression of ST6Gal-I mRNA and Level of a2,6-Sialylation of Glycoproteins in Bovine CL
ST6Gal-I mRNA and a2,6-sialic acid expression levels in each CL tissue and membrane fraction of CL tissue (early: n ¼ 4; developing: n ¼ 4; mid: n ¼ 4; late: n ¼ 4; regressed: n ¼ 4) were examined by quantitative RT-PCR and lectin blotting, using Sambucus sieboldiana agglutinin (SSA; product J218; J-Oil Mills). Localization of a2,6-sialic acid in each CL tissue sample (early: n ¼ 3; mid: n ¼ 3; regressed: n ¼ 3) was analyzed by lectin histochemistry assay using SSA.
Experiment 2: Effect of Luteolytic Factors on Expression of
ST6Gal-I mRNA and Level of a2,6-Sialylation of Cultured Mid-LSCs
To clarify whether luteolytic factors played a role in the expression of ST6Gal-I mRNA and the level of a2,6-sialylation in the bovine CL, the cultured mid-LSCs were exposed to 2.3 nM recombinant human TNFa (kindly donated by Dainippon Pharmaceutical), 2.5 nM recombinant bovine interferon c (IFNG; kindly donated by Dr. S. Inumaru, National Institute of Animal Health), 1.0 lM PGF2a (product P7652; Sigma-Aldrich) alone or TNFa in combination with IFNG for 24, 48, and 72 h. Additionally, the cultured midLSCs were exposed to 10 ng/ml luteinizing hormone (LH: product bLH-B6; United States Department of Agriculture) and 1.0 lM prostaglandin E2 (PGE: product P0409; Sigma-Aldrich) for 24 h. Doses for treatments were selected based on previous reports [33] [34] [35] [36] . After the culture, the expression of ST6Gal-I mRNA was determined by quantitative RT-PCR. TNF (2.3 nM) and IFNG (2.5 nM) induce the expression of Fas mRNA in cultured LSCs [34] . Induction of the expression of Fas mRNA by TNF (2.3 nM) and IFNG (2.5 nM) was confirmed in this experiment (Supplemental Fig. S1 ; all Supplemental Data are available online at www.biolreprod.org). The expression of a2,6-sialic acid in total cell lysates was assessed by SSA lectin blotting only in cells treated with PGF2a for 72 h.
Experiment 3: Effect of a2,6-Sialylation on Galactin-1-Enhanced Viability of Cultured Mid-and Late-LSCs
The level of a2,6-sialylation of mid-and late-LSCs in total cell lysates was measured by SSA lectin blotting. To investigate the effect of galectin-1 on cell viability of mid-and late-LSCs, these cells were incubated with or without recombinant galectin-1 (1000 ng/ml; product 1152-GA-050/CF; R&D Systems) for 24 h. Cell viability was determined by methyl tetrazolium (MTT) assay. In our previous study, galectin-1 (at 10, 100, and 1000 ng/ml) significantly increased the viability of cultured LSCs, and the greatest increase in the viability of LSCs was observed in the treatment with galectin-1 (1000 ng/ ml) [29] . Thus, we used 1000 ng/ml galectin-1 in the present study.
To remove sialic acid from cell surface glycoproteins, late-LSCs were treated with or without neuraminidase (0.1, 1.0, and 10 units/ml; product P0720S; New England BioLabs) for 1 h and washed. Then, cells were further incubated for 24 h, and a2,6-sialic acid expression was analyzed by SSA lectin blotting to confirm a reduction in the level of a2,6-sialylation by neuraminidase treatment. To examine whether a2,6-sialic acid inhibited the effect of galectin-1 on the viability of late-LSCs, cells were incubated with or without neuraminidase (10 units/ml) for 1 h and washed. Then cells were further incubated with or without recombinant galectin-1 (1000 ng/ml) for 24 h. Cell viability was determined using a WST-8 cell proliferation assay (343-07623; Dojindo).
Quantitative RT-PCR
Total RNA was extracted from cells using TRIsure (product BIO-38032; Bioline) according to the manufacturer's directions. One microgram of each total RNA was reverse transcribed using a ThermoScript reverse transcriptase (RT)-PCR system (product 11146-016; Invitrogen), and 10% of the reaction mixture was used in each PCR, using specific primers for ST6Gal-I from the bovine sequence (Table 1) . Quantification of mRNA expression was determined by iQ SYBR Green Supermix (product 170-8880; Bio-Rad Laboratories) assay, starting with 2 ng of reverse-transcribed total RNA. For quantification of mRNA expression levels, PCR was performed under the HASHIBA ET AL.
following conditions: 958C for 15 min, followed by 45 cycles of 948C for 15 sec, 608C for 20 sec, and 728C for 15 sec. The QuantiTect SYBR Green PCR system was used at elevated temperatures, resulting in reliable and sensitive quantification of the RT-PCR products with high linearity (Pearson correlation coefficient: r . 0.99). MRPL4 mRNA expression was used as an internal control as described previously [37] , and the expression of each gene was evaluated on the basis of the MRPL4 mRNA expression in the individual samples.
Western Blotting
Proteins were solubilized in SDS gel-loading buffer, and heated to 958C for 10 min. Samples (20 lg of protein/lane) were separated by SDS-PAGE and then transferred to a polyvinylidene fluoride membrane (product RPN303F; GE Healthcare). The membrane was washed in TBS-T (0.1% Tween 20 in TBS [25 mM Tris-HCl, 137 mM NaCl, pH 7.5]) and incubated in blocking buffer (5% nonfat dried milk in TBS-T) for 1 h at room temperature. After being washed, the membranes were incubated with galectin-1 antibody at 1:4000 dilution (product AF1152; R&D Systems) or b-actin (ACTB) antibody diluted to 1:10 000 (product A2228; Sigma-Aldrich) overnight at 48C. After being washed with TBS-T, the membrane was incubated with the appropriate secondary antibodies (horseradish peroxidase [HRP]-linked donkey anti-goat IgG [1:5000 dilution for galectin-1; product sc-2020; Santa Cruz Biotechnology] or HRP-linked sheep anti-mouse IgG [1:40 000 dilution for ACTB; product NA931; Amersham Biosciences]) for 1 h at room temperature. After samples were washed again with TBS-T, the signal was detected by chemiluminescence, using Immobilon Western chemiluminescent HRP substrate (product P36599; Millipore). b-Actin protein expression was used as an internal control for the experiments, using total cell lysates. The intensity of the immunological reaction in the tissues or cells was estimated by measuring the optical density in the defined area by computerized densitometry, using Image Lab version 4.0 software (Bio-Rad Laboratories).
Lectin Blotting
Protein samples (5 lg/lane) were subsequently separated by SDS-PAGE. Separated proteins were transferred onto a polyvinylidene fluoride membrane. The membrane was blocked with 5% BSA in TBS-T and then reacted with biotin-conjugated SSA (0.17 lg/ml) lectin in TBS-T for 1 h. After being washed again with TBS-T, the membrane was incubated with 0.17 lg/ml streptavidin conjugated to HRP (product 21130; Pierce Biotechnology). After being washed again with TBS-T, the reactive protein bands were detected by chemiluminescence, using Immobilon Western chemiluminescent HRP substrate as described above.
Lectin Histochemistry
CL tissues (2.0-3.0 g) stages were classified as early luteal (n ¼ 3), midluteal (n ¼ 4), late-luteal (n ¼ 3), and regressing luteal (n ¼ 5) and were fixed with 4% paraformaldehyde for histological analysis. Fixed tissues were embedded in paraffin according to the conventional method. Five-micrometerthick sections were dewaxed and washed in phosphate-buffered saline (PBS). 
ROLE OF Alpha2,6-Sialylation IN CORPUS LUTEUM
Subsequently, the sections were incubated at room temperature with 3% hydrogen peroxide in distilled water for 20 min, and avidin/biotin blocking solution (Vector Laboratories) for 15 min for each reagent, followed by Carbofree blocking solution (Vector Laboratories) for 60 min. Then, the sections were incubated with biotin-conjugated SSA lectin (1.0 lg/ml) at 48C overnight. After sections were washed twice in PBS, the reaction sites were visualized using Vectastain ABC Elite kit (Vector Laboratories) for 60 min at room temperature and 3,3 0 -diaminobenzidine (DAB; ImmPACT) peroxidase substrate kit (Vector Laboratories) for 5 min. The sections were counterstained for 2 min with hematoxylin and observed under a light microscope (BX51; Olympus) using a 203 objective lens. Control sections were incubated with PBS instead of SSA, and the disappearance of signals in both endothelial cells and luteal cells was confirmed. LSCs and luteal endothelial cells were identified by localization and morphological features of the cells [38, 39] . Because SSA lectin reacts against the endothelial cells [40] , SSA lectin-positive cells, in addition to LSCs, were judged to be luteal endothelial cells, and we observed that SSA lectin reacted against the endothelial cells.
Viability Assay
WST-8, a kind of MTT assay, is a yellow tetrazolium salt that is reduced to formazan by live cells containing active mitochondria. The culture medium was replaced with 100 ll of D/F medium without phenol red, and 10 ll of WST-8 was added to each well. Cells were then incubated for 4 h at 38.58C. The absorbance was read at 450 nm, using a microplate reader (model 450; BioRad).
Statistical Analysis
All experimental data are means 6 SEM. The statistically significant differences were assessed using Student t-test and one-way ANOVA, followed by Dunnett multiple comparison test or two-way ANOVA followed by Tukey multiple comparison test, using the Prism version 6.0 software (GraphPad). Probabilities less than 5% (P , 0.05) were considered statistically significant.
RESULTS
Experiment 1: Cyclic Changes in Expression of ST6Gal-I mRNA and Level of a2,6-Sialylation of Glycoproteins in Bovine CL
The expression of ST6Gal-I mRNA in the bovine CL was significantly higher during the regressed-luteal stage than during the developing and mid-luteal stages (Fig. 1A) . The level of a2,6-sialylation in the membrane fraction was higher during the regressed-luteal stage than during the other luteal stages (Fig. 1B) . Lectin histochemistry revealed that a2,6-sialylated glycoconjugates were localized to luteal endothelial cells throughout the estrous cycle (Fig. 2, arrows) . In the regressed-luteal stage, a2,6-sialylated glycoconjugates concentrated to the plasma membrane of LSCs (Fig. 2) . The expression of ST6Gal-I mRNA was significantly increased by treatment with PGF2a for 72 h, but it was not affected by treatment with TNFa, IFNG, or a combination of TNFa and IFNG for 24, 48, or 72 h (Fig. 3A) . Moreover, the expression of ST6Gal-I mRNA was not affected by treatment with LH or PGE for 24 h (Supplemental Fig. S2 ). The level of a2,6-sialylated glycoproteins in total cell lysates was also significantly increased by treatment with PGF2a for 72 h (Fig.  3B) . The level of a2,6-sialylated glycoproteins of late-LSCs was higher than that of mid-LSCs (Fig. 4A) . Galectin-1 (1.0 lg/ml) increased the viability of mid-LSCs, while it did not affect the viability of late-LSCs (Fig. 4, B and C) . Neuraminidase treatment (1.0 and 10 units/ml) decreased the level of a2,6-sialylation in total cell lysates of late-LSCs (Fig. 5A) . Pretreatment of late-LSCs with neuraminidase (10 units/ml) restored the ability of galectin-1 to increase their viability (Fig.  5B) .
DISCUSSION
The present study revealed that a2,6-sialylation increased during luteolysis in the bovine CL and that the increase was regulated by luteolytic PGF2a through enhancing the expression of a sialyltransferase, ST6GAL-I in LSCs. An increased a2,6-sialylation on membrane glycoprotein of LSCs during the late-luteal stage attenuated the effect of galectin-1 on luteal cell viability. Removal of a2,6-sialic acids by a treatment with neuraminidase restored the effect of galectin-1, suggesting that a2,6-sialylation is involved in the regulation of luteolysis by inhibiting the binding of galectin-1 to the glycans.
As mentioned above, extracellular galectin-1 promoted cell viability in bovine LSCs, suggesting that galectin-1 has a luteotropic function in the bovine CL [29] . In that study, we also showed that the amount of galectin-1 on the cell membrane of the CL decreased during luteolysis. However, in the present study, the abundance of galectin-1 in both cytoplasmic and cell membrane fractions of the CL did not change during the estrous cycle (Supplemental Fig. S3 ). This reminds us that the change in glycan structure to decrease the binding of galectin-1 to glycan on cell membrane may contribute to a loss of galectin-1 on the cell membrane of LSCs during luteolysis. However, the mechanism that inhibited the binding of galectin-1 to glycans during luteolysis remained unclear. Galectins have an affinity for LacNAc, whereas modifications of LacNAc structure influence the affinity for each galectin subtype. It is well known that a2,6-sialylation of the terminal galactose, which is catalyzed by ST6GAL-I, interferes with the binding of galectin-1 [23] [24] [25] . We revealed here that the level of a2,6-sialylation increased during the lateluteal stage and was highest during the regressed-luteal stage where galectin-1 expression on cell membrane decreased [29] . These findings suggest that a2,6-sialylation on the glycan ligand for galectin-1 inhibits the binding of galectin-1 to the glycan, resulting in a decreased localization of galectin-1 on cell membrane of LSCs. Consequently, the survival signal induced by galectin-1 may become weak in LSCs during 0 lM) for 72 h. The resultant signal was detected by chemiluminescence and quantitated by computer-assisted densitometry. Data are a2,6-sialylated proteins-to-ACTB protein relative ratios. All values are means 6 SEM. All experiments were repeated more than three times, and data were statistically analyzed using Student t-test and ANOVA, followed by Dunnett multiple comparison test. *Significant differences compared with control for 72 h (P , 0.05). TþI ¼ TNFa þ IFNG treatment.
ROLE OF Alpha2,6-Sialylation IN CORPUS LUTEUM luteolysis. In ST6Gal-I-deficient mice, vascularization is decreased, and the platelet endothelial cell adhesion molecule (PECAM), which is important for cell adhesion of endothelial cells, is unable to remain on the cell surface and incompletely transduces inhibitory signals such as in its antiapoptotic role [41] . In the present study, a2,6-sialic acid localized at the luteal endothelial cells. These findings suggest that a2,6-sialylation plays important roles of vascularization.
Galectin-1 has a role in a variety of biological processes, such as cell adhesion, invasion, cell migration, cell survival, and cell death [42] . In mouse, galectin-1 strongly expresses during luteolysis, and the expression of ST6Gal-I mRNA is enhanced in the regressing CL, suggesting that the interaction between galectin-1 and a2,6-sialylation plays an important role in luteolysis [43] . Galectin-1 is also likely to have a luteotropic role in the human CL, and an inhibition of the binding of galectin-1 to glycan caused by a2,6-sialylation possibly contributes to the induction of luteolysis in women [44] . In the bovine CL, galectin-1 increases the viability of mid-LSCs but does not affect the viability of late-LSCs which contained abundant a2,6-sialylated glycoproteins, suggesting that a2,6-sialylation in late-LSCs attenuates the effect of galectin-1. When the late-LSCs were pretreated with neuraminidase to remove sialic acid residues, galectin-1 could increase the cell viability in late-LSCs, further supporting a luteolytic role of a2,6-sialic acids.
Expression of ST6GAL-I mRNA was enhanced by PGF2a but not by other luteolytic factors (Fig. 3) . In human luteinizing granulosa cells, luteotropic factors (PGE2 and human chorionic gonadotropin) strongly suppress the expression of ST6Gal-I mRNA [44] . However, in the present study, PGE2 and luteinizing hormone did not suppress the expression of ST6Gal-I mRNA in bovine LSCs (Supplemental Fig. S2 ). In contrast, PGF2a significantly enhanced the expression of ST6Gal-I in bovine LSCs, whereas other luteolytic factors including TNFa and IFNG had no effect. PGF2a regulates luteal function by activating protein kinase (PK) C pathways in luteolysis [33, 45] . In addition, activation of PKC pathway was found to stimulate a2,6-sialylation in Madin-Darby canine kidney cells [46] . These findings suggest that activation of the PKC pathway by PGF2a contributes to the increase of a2,6-sialylation in bovine LSCs during luteolysis.
Although a2,6-sialylation on glycoproteins likely has a role in luteolysis in cows, the proteins carrying a2,6-sialic acid are unclear. We previously revealed that galectin-1 enhances the cell viability of mid-LSCs by binding to the glycans of vascular endothelial growth factor receptor-2 (VEGFR-2), and the protein expression and stability of VEGFR-2 on the cell surface   FIG. 4 . Differences in a2,6-sialylation and the effect of galectin-1 in cultured mid-and late-LSCs. A) Representative SSA lectin blotting is shown of glycoproteins and ACTB in total cell lysates of mid-and late-LSCs. B and C) Mid-and late-LSCs were incubated with or without galectin-1 (1.0 lg/ml) for 24 h. All values are means 6 SEM. Data were statistically analyzed using Student t-tests. *Significant differences compared with control (P , 0.05).
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require the binding of galectin-1 to glycan of VEGFR-2 in bovine LSCs [29] . Since glycosylation of receptors is important in cell surface retention of various receptors through interaction with galectins [47] , inhibition of the binding of galectin-1 to the glycan of VEGFR-2 by a2,6-sialylation may decrease in the VEGFR-2-mediated survival signal in LSCs during luteolysis. However, it is unlikely that the sugar chain on VEGFR-2 contains abundant a2,6-sialic acids, because we could not find a band with an approximate molecular mass for VEGFR-2 (220 kDa) in the SSA lectin blotting analysis. Further studies are required to reveal the proteins carrying a2,6-sialic acid residues.
The overall findings suggest that the a2,6-sialylation stimulated by PGF2a inhibited the interaction between galectin-1 and glycan, contributing to luteolysis by reducing the galectin-1 effect on luteal cell viability in cattle.
